Ramsay Partners with IMS MAXIMS for Next Decade

IMS MAXIMSRamsay Health Care UK, one of the leading providers of independent hospital services in England, has signed a 10-year contract with IMS MAXIMS to provide an open source electronic patient record (EPR) system and clinical modules to improve patient satisfaction and outcomes.

The agreement aims to help the independent healthcare sector provider achieve its commitment to continuous service improvement. "It's about putting the patient at the heart of everything we do," says Andrew Till, corporate service director at Ramsay Health Care UK. "We are always striving to provide a safe, high quality seamless service and IT is a cornerstone to achieving this mission."

The contract will see the implementation of the full openMAXIMS product suite released to healthcare providers last summer. Till said he was confident with IMS MAXIMS' open source development processes to enhancing the code in the future.

The suite includes a patient administration system, and solutions for order communications and results, eDischarge, integrated care pathways, theatre scheduling, bed management and clinical noting.

Other functionality to be introduced as part of the contract includes electronic prescribing, medical device integration, voice recognition, direct booking capability, and a pharmacy system.

The move away from paper records will see clinicians access patient information at anytime, in any location, via desktop and mobile devices, supporting productivity improvements. Till said the need to have patient information "readily available" for clinicians at the bedside would increase response times when accessing patient information at the point-of-care.

Furthermore, the integration capabilities of IMS MAXIMS means there is less manual intervention when integrating data across the IT solution set, resulting in a quicker and more coordinated service for both clinicians and patients.

The openMAXIMS technology will be deployed across all 32 Ramsay Health Care UK sites, with an average of 1,500 active concurrent users of the system at any one time.

Till said IMS MAXIMS’ reputation and the range of functionality it could offer was key to selecting the company as the preferred supplier: "IMS MAXIMS is well established in the UK health market. We saw a number of principles in the company that reflected our own ethos at Ramsay such as integrity and professionalism, which wholly supported the commitment to enter a 10-year deal."

Shane Tickell, CEO of IMS MAXIMS, concluded: "As no two healthcare providers, or indeed, no two clinicians are the same, we know how important it is to ensure we meet the clinical, management and financial needs of any organisation when scoping healthcare technology. This contract reflects the hard work and time invested to understand Ramsay’s requirements for a strategic IT solution.

"As we look forward to this long-term partnership, I believe the extensive knowledge and experience of both organisations will enable the delivery of safer, more efficient care for the benefit of patients."

About Ramsay Health Care UK
Ramsay Health Care UK is one of the leading private hospital operators in the UK with 36 facilities across England. These provide a comprehensive range of elective care specialties to insured, self-pay and NHS patients.

About openMAXIMS
Electronic patient record (EPR) provider IMS MAXIMS released the open source code for its full MAXIMS suite, including its electronic patient record and patient administration system (PAS) free of charge to the NHS in June 2014. Earlier this year, IMS MAXIMS was named the only open source EPR and PAS supplier in a ‘catalogue’ designed to support NHS England’s technology fund two, officially called the Integrated Digital Care Fund.

About IMS MAXIMS
IMS MAXIMS is an electronic patient record provider working towards better, safer patient care. Specialists in developing clinical and administrative software solutions for healthcare providers, IMS MAXIMS currently supports more than 150 organisations, 11 million patient records in the UK, and 1.9 million patient records in Ireland, approx 50% of the population, as well as 20,000 users of IMS MAXIMS products.

Most Popular Now

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...